Dr. Donald E Morel is a private investor, educator, and philanthropist. He retired in June 2015 after a twenty three year career at West Pharmaceutical Services Inc (NYSE:WST) having served as Chairman and CEO from 2002 until his retirement. During his tenure West was the top performing dividend paying healthcare stock on the NYSE.
He currently serves as the Chairman of the Board of Trustees of the Franklin Institute in Philadelphia Chairs the Foundation Board for the American Oncologic Hospital of Fox Chase Cancer Center. Dr. Morel serves on the Boards of Integra Life Sciences Holdings Corporation, Catalent Corporation, and Stevanato Group s.p.A.
He is a Trustee of Lafayette College and serves as a Director of No Barriers USA and the Travis Manion Foundation. He holds degrees from Lafayette College and Cornell University in Engineering and Veterinary Medicine.